nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—GUCY1A2—prostate gland—urinary bladder cancer	0.0303	0.072	CbGeAlD
Nitroglycerin—GUCY1A3—prostate gland—urinary bladder cancer	0.0191	0.0454	CbGeAlD
Nitroglycerin—GUCY1B3—prostate gland—urinary bladder cancer	0.019	0.045	CbGeAlD
Nitroglycerin—NPR1—prostate gland—urinary bladder cancer	0.0177	0.0421	CbGeAlD
Nitroglycerin—GUCY1A2—female reproductive system—urinary bladder cancer	0.0166	0.0393	CbGeAlD
Nitroglycerin—GUCY1A3—seminal vesicle—urinary bladder cancer	0.0162	0.0384	CbGeAlD
Nitroglycerin—ALDH2—prostate gland—urinary bladder cancer	0.0161	0.0382	CbGeAlD
Nitroglycerin—GUCY1B3—seminal vesicle—urinary bladder cancer	0.016	0.0381	CbGeAlD
Nitroglycerin—NPR1—seminal vesicle—urinary bladder cancer	0.015	0.0356	CbGeAlD
Nitroglycerin—ALDH2—seminal vesicle—urinary bladder cancer	0.0136	0.0323	CbGeAlD
Nitroglycerin—NPR1—epithelium—urinary bladder cancer	0.013	0.0309	CbGeAlD
Nitroglycerin—GUCY1A3—renal system—urinary bladder cancer	0.013	0.0309	CbGeAlD
Nitroglycerin—GUCY1B3—renal system—urinary bladder cancer	0.0129	0.0307	CbGeAlD
Nitroglycerin—GUCY1A3—urethra—urinary bladder cancer	0.0128	0.0304	CbGeAlD
Nitroglycerin—GUCY1B3—urethra—urinary bladder cancer	0.0127	0.0301	CbGeAlD
Nitroglycerin—NPR1—smooth muscle tissue—urinary bladder cancer	0.0126	0.0298	CbGeAlD
Nitroglycerin—NPR1—renal system—urinary bladder cancer	0.0121	0.0287	CbGeAlD
Nitroglycerin—NPR1—urethra—urinary bladder cancer	0.0119	0.0282	CbGeAlD
Nitroglycerin—ALDH2—smooth muscle tissue—urinary bladder cancer	0.0114	0.0271	CbGeAlD
Nitroglycerin—ALDH2—renal system—urinary bladder cancer	0.011	0.0261	CbGeAlD
Nitroglycerin—ALDH2—urethra—urinary bladder cancer	0.0108	0.0256	CbGeAlD
Nitroglycerin—GUCY1A3—female reproductive system—urinary bladder cancer	0.0104	0.0248	CbGeAlD
Nitroglycerin—GUCY1B3—female reproductive system—urinary bladder cancer	0.0104	0.0246	CbGeAlD
Nitroglycerin—GUCY1A2—lymph node—urinary bladder cancer	0.00969	0.023	CbGeAlD
Nitroglycerin—NPR1—female reproductive system—urinary bladder cancer	0.00968	0.023	CbGeAlD
Nitroglycerin—GUCY1A3—vagina—urinary bladder cancer	0.00943	0.0224	CbGeAlD
Nitroglycerin—GUCY1B3—vagina—urinary bladder cancer	0.00936	0.0222	CbGeAlD
Nitroglycerin—ALDH2—female reproductive system—urinary bladder cancer	0.00879	0.0209	CbGeAlD
Nitroglycerin—NPR1—vagina—urinary bladder cancer	0.00876	0.0208	CbGeAlD
Nitroglycerin—ALDH2—vagina—urinary bladder cancer	0.00795	0.0189	CbGeAlD
Nitroglycerin—GUCY1A3—lymph node—urinary bladder cancer	0.0061	0.0145	CbGeAlD
Nitroglycerin—GUCY1B3—lymph node—urinary bladder cancer	0.00606	0.0144	CbGeAlD
Nitroglycerin—NPR1—lymph node—urinary bladder cancer	0.00566	0.0134	CbGeAlD
Nitroglycerin—ALDH2—lymph node—urinary bladder cancer	0.00514	0.0122	CbGeAlD
Nitroglycerin—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00112	0.00194	CcSEcCtD
Nitroglycerin—Infection—Fluorouracil—urinary bladder cancer	0.00112	0.00193	CcSEcCtD
Nitroglycerin—Renal failure acute—Doxorubicin—urinary bladder cancer	0.00112	0.00193	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00111	0.00192	CcSEcCtD
Nitroglycerin—Skin disorder—Gemcitabine—urinary bladder cancer	0.00111	0.00192	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00111	0.00191	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.0011	0.00191	CcSEcCtD
Nitroglycerin—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.0011	0.0019	CcSEcCtD
Nitroglycerin—Hot flush—Doxorubicin—urinary bladder cancer	0.0011	0.0019	CcSEcCtD
Nitroglycerin—Tachycardia—Fluorouracil—urinary bladder cancer	0.0011	0.0019	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.00109	0.00189	CcSEcCtD
Nitroglycerin—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.00109	0.00189	CcSEcCtD
Nitroglycerin—Urticaria—Thiotepa—urinary bladder cancer	0.00108	0.00187	CcSEcCtD
Nitroglycerin—Vertigo—Etoposide—urinary bladder cancer	0.00107	0.00186	CcSEcCtD
Nitroglycerin—Body temperature increased—Thiotepa—urinary bladder cancer	0.00107	0.00186	CcSEcCtD
Nitroglycerin—Abdominal pain—Thiotepa—urinary bladder cancer	0.00107	0.00186	CcSEcCtD
Nitroglycerin—Hypotension—Gemcitabine—urinary bladder cancer	0.00107	0.00185	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00107	0.00184	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Doxorubicin—urinary bladder cancer	0.00106	0.00184	CcSEcCtD
Nitroglycerin—Infection—Cisplatin—urinary bladder cancer	0.00106	0.00183	CcSEcCtD
Nitroglycerin—Loss of consciousness—Etoposide—urinary bladder cancer	0.00105	0.00182	CcSEcCtD
Nitroglycerin—Hypotension—Fluorouracil—urinary bladder cancer	0.00105	0.00182	CcSEcCtD
Nitroglycerin—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00105	0.00181	CcSEcCtD
Nitroglycerin—Tachycardia—Cisplatin—urinary bladder cancer	0.00104	0.0018	CcSEcCtD
Nitroglycerin—Skin disorder—Cisplatin—urinary bladder cancer	0.00104	0.00179	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00103	0.00178	CcSEcCtD
Nitroglycerin—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00103	0.00177	CcSEcCtD
Nitroglycerin—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00102	0.00176	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00102	0.00176	CcSEcCtD
Nitroglycerin—Somnolence—Gemcitabine—urinary bladder cancer	0.00102	0.00176	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00101	0.00175	CcSEcCtD
Nitroglycerin—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00101	0.00174	CcSEcCtD
Nitroglycerin—Dyspnoea—Fluorouracil—urinary bladder cancer	0.001	0.00173	CcSEcCtD
Nitroglycerin—Hypersensitivity—Thiotepa—urinary bladder cancer	0.001	0.00173	CcSEcCtD
Nitroglycerin—Somnolence—Fluorouracil—urinary bladder cancer	0.001	0.00173	CcSEcCtD
Nitroglycerin—Hypotension—Cisplatin—urinary bladder cancer	0.000996	0.00172	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000987	0.00171	CcSEcCtD
Nitroglycerin—Confusional state—Etoposide—urinary bladder cancer	0.000985	0.0017	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000976	0.00169	CcSEcCtD
Nitroglycerin—Asthenia—Thiotepa—urinary bladder cancer	0.000975	0.00169	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000971	0.00168	CcSEcCtD
Nitroglycerin—Infection—Etoposide—urinary bladder cancer	0.00097	0.00168	CcSEcCtD
Nitroglycerin—Pruritus—Thiotepa—urinary bladder cancer	0.000962	0.00166	CcSEcCtD
Nitroglycerin—Paraesthesia—Cisplatin—urinary bladder cancer	0.000957	0.00165	CcSEcCtD
Nitroglycerin—Tachycardia—Etoposide—urinary bladder cancer	0.000953	0.00165	CcSEcCtD
Nitroglycerin—Dyspnoea—Cisplatin—urinary bladder cancer	0.00095	0.00164	CcSEcCtD
Nitroglycerin—Skin disorder—Etoposide—urinary bladder cancer	0.000948	0.00164	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000944	0.00163	CcSEcCtD
Nitroglycerin—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000942	0.00163	CcSEcCtD
Nitroglycerin—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.000941	0.00163	CcSEcCtD
Nitroglycerin—Angina pectoris—Epirubicin—urinary bladder cancer	0.000938	0.00162	CcSEcCtD
Nitroglycerin—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000927	0.0016	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00092	0.00159	CcSEcCtD
Nitroglycerin—Infestation—Methotrexate—urinary bladder cancer	0.000917	0.00158	CcSEcCtD
Nitroglycerin—Drowsiness—Methotrexate—urinary bladder cancer	0.000917	0.00158	CcSEcCtD
Nitroglycerin—Infestation NOS—Methotrexate—urinary bladder cancer	0.000917	0.00158	CcSEcCtD
Nitroglycerin—Hypotension—Etoposide—urinary bladder cancer	0.000912	0.00158	CcSEcCtD
Nitroglycerin—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000904	0.00156	CcSEcCtD
Nitroglycerin—Dizziness—Thiotepa—urinary bladder cancer	0.000899	0.00155	CcSEcCtD
Nitroglycerin—Stomatitis—Methotrexate—urinary bladder cancer	0.000894	0.00154	CcSEcCtD
Nitroglycerin—Urticaria—Fluorouracil—urinary bladder cancer	0.000893	0.00154	CcSEcCtD
Nitroglycerin—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000889	0.00154	CcSEcCtD
Nitroglycerin—Sweating—Methotrexate—urinary bladder cancer	0.000879	0.00152	CcSEcCtD
Nitroglycerin—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000878	0.00152	CcSEcCtD
Nitroglycerin—Paraesthesia—Etoposide—urinary bladder cancer	0.000877	0.00151	CcSEcCtD
Nitroglycerin—Dyspnoea—Etoposide—urinary bladder cancer	0.000871	0.0015	CcSEcCtD
Nitroglycerin—Somnolence—Etoposide—urinary bladder cancer	0.000868	0.0015	CcSEcCtD
Nitroglycerin—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000868	0.0015	CcSEcCtD
Nitroglycerin—Vomiting—Thiotepa—urinary bladder cancer	0.000864	0.00149	CcSEcCtD
Nitroglycerin—Infestation—Epirubicin—urinary bladder cancer	0.000858	0.00148	CcSEcCtD
Nitroglycerin—Drowsiness—Epirubicin—urinary bladder cancer	0.000858	0.00148	CcSEcCtD
Nitroglycerin—Infestation NOS—Epirubicin—urinary bladder cancer	0.000858	0.00148	CcSEcCtD
Nitroglycerin—Rash—Thiotepa—urinary bladder cancer	0.000857	0.00148	CcSEcCtD
Nitroglycerin—Dermatitis—Thiotepa—urinary bladder cancer	0.000856	0.00148	CcSEcCtD
Nitroglycerin—Headache—Thiotepa—urinary bladder cancer	0.000852	0.00147	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000843	0.00146	CcSEcCtD
Nitroglycerin—Body temperature increased—Cisplatin—urinary bladder cancer	0.000843	0.00146	CcSEcCtD
Nitroglycerin—Stomatitis—Epirubicin—urinary bladder cancer	0.000837	0.00145	CcSEcCtD
Nitroglycerin—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000828	0.00143	CcSEcCtD
Nitroglycerin—Sweating—Epirubicin—urinary bladder cancer	0.000823	0.00142	CcSEcCtD
Nitroglycerin—Asthenia—Gemcitabine—urinary bladder cancer	0.00082	0.00142	CcSEcCtD
Nitroglycerin—Pharyngitis—Methotrexate—urinary bladder cancer	0.000817	0.00141	CcSEcCtD
Nitroglycerin—Pruritus—Gemcitabine—urinary bladder cancer	0.000809	0.0014	CcSEcCtD
Nitroglycerin—Nausea—Thiotepa—urinary bladder cancer	0.000807	0.0014	CcSEcCtD
Nitroglycerin—Feeling abnormal—Etoposide—urinary bladder cancer	0.000805	0.00139	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000798	0.00138	CcSEcCtD
Nitroglycerin—Pruritus—Fluorouracil—urinary bladder cancer	0.000795	0.00137	CcSEcCtD
Nitroglycerin—Drowsiness—Doxorubicin—urinary bladder cancer	0.000794	0.00137	CcSEcCtD
Nitroglycerin—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000794	0.00137	CcSEcCtD
Nitroglycerin—Infestation—Doxorubicin—urinary bladder cancer	0.000794	0.00137	CcSEcCtD
Nitroglycerin—Visual impairment—Methotrexate—urinary bladder cancer	0.000793	0.00137	CcSEcCtD
Nitroglycerin—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000785	0.00136	CcSEcCtD
Nitroglycerin—Bradycardia—Epirubicin—urinary bladder cancer	0.000784	0.00136	CcSEcCtD
Nitroglycerin—Urticaria—Etoposide—urinary bladder cancer	0.000776	0.00134	CcSEcCtD
Nitroglycerin—Stomatitis—Doxorubicin—urinary bladder cancer	0.000774	0.00134	CcSEcCtD
Nitroglycerin—Rhinitis—Epirubicin—urinary bladder cancer	0.000772	0.00133	CcSEcCtD
Nitroglycerin—Abdominal pain—Etoposide—urinary bladder cancer	0.000772	0.00133	CcSEcCtD
Nitroglycerin—Body temperature increased—Etoposide—urinary bladder cancer	0.000772	0.00133	CcSEcCtD
Nitroglycerin—Asthenia—Cisplatin—urinary bladder cancer	0.000765	0.00132	CcSEcCtD
Nitroglycerin—Pharyngitis—Epirubicin—urinary bladder cancer	0.000765	0.00132	CcSEcCtD
Nitroglycerin—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000764	0.00132	CcSEcCtD
Nitroglycerin—Sweating—Doxorubicin—urinary bladder cancer	0.000761	0.00132	CcSEcCtD
Nitroglycerin—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000759	0.00131	CcSEcCtD
Nitroglycerin—Angiopathy—Methotrexate—urinary bladder cancer	0.000747	0.00129	CcSEcCtD
Nitroglycerin—Immune system disorder—Methotrexate—urinary bladder cancer	0.000744	0.00128	CcSEcCtD
Nitroglycerin—Dizziness—Fluorouracil—urinary bladder cancer	0.000743	0.00128	CcSEcCtD
Nitroglycerin—Visual impairment—Epirubicin—urinary bladder cancer	0.000742	0.00128	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000742	0.00128	CcSEcCtD
Nitroglycerin—Vomiting—Gemcitabine—urinary bladder cancer	0.000727	0.00126	CcSEcCtD
Nitroglycerin—Bradycardia—Doxorubicin—urinary bladder cancer	0.000726	0.00125	CcSEcCtD
Nitroglycerin—Mental disorder—Methotrexate—urinary bladder cancer	0.000721	0.00125	CcSEcCtD
Nitroglycerin—Rash—Gemcitabine—urinary bladder cancer	0.000721	0.00125	CcSEcCtD
Nitroglycerin—Dermatitis—Gemcitabine—urinary bladder cancer	0.00072	0.00124	CcSEcCtD
Nitroglycerin—Hypersensitivity—Etoposide—urinary bladder cancer	0.000719	0.00124	CcSEcCtD
Nitroglycerin—Erythema—Methotrexate—urinary bladder cancer	0.000717	0.00124	CcSEcCtD
Nitroglycerin—Headache—Gemcitabine—urinary bladder cancer	0.000716	0.00124	CcSEcCtD
Nitroglycerin—Flushing—Epirubicin—urinary bladder cancer	0.000715	0.00124	CcSEcCtD
Nitroglycerin—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000715	0.00124	CcSEcCtD
Nitroglycerin—Vomiting—Fluorouracil—urinary bladder cancer	0.000715	0.00124	CcSEcCtD
Nitroglycerin—Rhinitis—Doxorubicin—urinary bladder cancer	0.000715	0.00123	CcSEcCtD
Nitroglycerin—Rash—Fluorouracil—urinary bladder cancer	0.000709	0.00122	CcSEcCtD
Nitroglycerin—Dermatitis—Fluorouracil—urinary bladder cancer	0.000708	0.00122	CcSEcCtD
Nitroglycerin—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000708	0.00122	CcSEcCtD
Nitroglycerin—Headache—Fluorouracil—urinary bladder cancer	0.000704	0.00122	CcSEcCtD
Nitroglycerin—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000702	0.00121	CcSEcCtD
Nitroglycerin—Asthenia—Etoposide—urinary bladder cancer	0.000701	0.00121	CcSEcCtD
Nitroglycerin—Angiopathy—Epirubicin—urinary bladder cancer	0.000699	0.00121	CcSEcCtD
Nitroglycerin—Immune system disorder—Epirubicin—urinary bladder cancer	0.000696	0.0012	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000694	0.0012	CcSEcCtD
Nitroglycerin—Pruritus—Etoposide—urinary bladder cancer	0.000691	0.00119	CcSEcCtD
Nitroglycerin—Arrhythmia—Epirubicin—urinary bladder cancer	0.000688	0.00119	CcSEcCtD
Nitroglycerin—Visual impairment—Doxorubicin—urinary bladder cancer	0.000687	0.00119	CcSEcCtD
Nitroglycerin—Nausea—Gemcitabine—urinary bladder cancer	0.000679	0.00117	CcSEcCtD
Nitroglycerin—Vomiting—Cisplatin—urinary bladder cancer	0.000678	0.00117	CcSEcCtD
Nitroglycerin—Vision blurred—Methotrexate—urinary bladder cancer	0.000675	0.00117	CcSEcCtD
Nitroglycerin—Mental disorder—Epirubicin—urinary bladder cancer	0.000675	0.00117	CcSEcCtD
Nitroglycerin—Rash—Cisplatin—urinary bladder cancer	0.000672	0.00116	CcSEcCtD
Nitroglycerin—Dermatitis—Cisplatin—urinary bladder cancer	0.000671	0.00116	CcSEcCtD
Nitroglycerin—Erythema—Epirubicin—urinary bladder cancer	0.000671	0.00116	CcSEcCtD
Nitroglycerin—Nausea—Fluorouracil—urinary bladder cancer	0.000668	0.00115	CcSEcCtD
Nitroglycerin—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000662	0.00114	CcSEcCtD
Nitroglycerin—Flushing—Doxorubicin—urinary bladder cancer	0.000662	0.00114	CcSEcCtD
Nitroglycerin—Angiopathy—Doxorubicin—urinary bladder cancer	0.000647	0.00112	CcSEcCtD
Nitroglycerin—Dizziness—Etoposide—urinary bladder cancer	0.000646	0.00112	CcSEcCtD
Nitroglycerin—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000644	0.00111	CcSEcCtD
Nitroglycerin—Vertigo—Methotrexate—urinary bladder cancer	0.000644	0.00111	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000642	0.00111	CcSEcCtD
Nitroglycerin—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000637	0.0011	CcSEcCtD
Nitroglycerin—Nausea—Cisplatin—urinary bladder cancer	0.000633	0.00109	CcSEcCtD
Nitroglycerin—Vision blurred—Epirubicin—urinary bladder cancer	0.000632	0.00109	CcSEcCtD
Nitroglycerin—Mental disorder—Doxorubicin—urinary bladder cancer	0.000625	0.00108	CcSEcCtD
Nitroglycerin—Vomiting—Etoposide—urinary bladder cancer	0.000621	0.00107	CcSEcCtD
Nitroglycerin—Erythema—Doxorubicin—urinary bladder cancer	0.000621	0.00107	CcSEcCtD
Nitroglycerin—Agitation—Epirubicin—urinary bladder cancer	0.000616	0.00106	CcSEcCtD
Nitroglycerin—Rash—Etoposide—urinary bladder cancer	0.000616	0.00106	CcSEcCtD
Nitroglycerin—Dermatitis—Etoposide—urinary bladder cancer	0.000615	0.00106	CcSEcCtD
Nitroglycerin—Headache—Etoposide—urinary bladder cancer	0.000612	0.00106	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000606	0.00105	CcSEcCtD
Nitroglycerin—Vertigo—Epirubicin—urinary bladder cancer	0.000603	0.00104	CcSEcCtD
Nitroglycerin—Syncope—Epirubicin—urinary bladder cancer	0.000601	0.00104	CcSEcCtD
Nitroglycerin—Palpitations—Epirubicin—urinary bladder cancer	0.000593	0.00102	CcSEcCtD
Nitroglycerin—Confusional state—Methotrexate—urinary bladder cancer	0.00059	0.00102	CcSEcCtD
Nitroglycerin—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000589	0.00102	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000585	0.00101	CcSEcCtD
Nitroglycerin—Vision blurred—Doxorubicin—urinary bladder cancer	0.000585	0.00101	CcSEcCtD
Nitroglycerin—Infection—Methotrexate—urinary bladder cancer	0.000581	0.001	CcSEcCtD
Nitroglycerin—Nausea—Etoposide—urinary bladder cancer	0.00058	0.001	CcSEcCtD
Nitroglycerin—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000574	0.000991	CcSEcCtD
Nitroglycerin—Agitation—Doxorubicin—urinary bladder cancer	0.00057	0.000985	CcSEcCtD
Nitroglycerin—Skin disorder—Methotrexate—urinary bladder cancer	0.000568	0.000982	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000567	0.00098	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000565	0.000977	CcSEcCtD
Nitroglycerin—Vertigo—Doxorubicin—urinary bladder cancer	0.000558	0.000963	CcSEcCtD
Nitroglycerin—Syncope—Doxorubicin—urinary bladder cancer	0.000556	0.000961	CcSEcCtD
Nitroglycerin—Confusional state—Epirubicin—urinary bladder cancer	0.000552	0.000954	CcSEcCtD
Nitroglycerin—Palpitations—Doxorubicin—urinary bladder cancer	0.000548	0.000947	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000547	0.000946	CcSEcCtD
Nitroglycerin—Hypotension—Methotrexate—urinary bladder cancer	0.000547	0.000944	CcSEcCtD
Nitroglycerin—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000545	0.000942	CcSEcCtD
Nitroglycerin—Infection—Epirubicin—urinary bladder cancer	0.000544	0.000939	CcSEcCtD
Nitroglycerin—Shock—Epirubicin—urinary bladder cancer	0.000539	0.00093	CcSEcCtD
Nitroglycerin—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000537	0.000927	CcSEcCtD
Nitroglycerin—Tachycardia—Epirubicin—urinary bladder cancer	0.000534	0.000923	CcSEcCtD
Nitroglycerin—Skin disorder—Epirubicin—urinary bladder cancer	0.000532	0.000919	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000529	0.000914	CcSEcCtD
Nitroglycerin—Paraesthesia—Methotrexate—urinary bladder cancer	0.000525	0.000907	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000525	0.000906	CcSEcCtD
Nitroglycerin—Dyspnoea—Methotrexate—urinary bladder cancer	0.000521	0.000901	CcSEcCtD
Nitroglycerin—Somnolence—Methotrexate—urinary bladder cancer	0.00052	0.000898	CcSEcCtD
Nitroglycerin—Hypotension—Epirubicin—urinary bladder cancer	0.000511	0.000884	CcSEcCtD
Nitroglycerin—Confusional state—Doxorubicin—urinary bladder cancer	0.000511	0.000882	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000506	0.000875	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000505	0.000872	CcSEcCtD
Nitroglycerin—Infection—Doxorubicin—urinary bladder cancer	0.000503	0.000869	CcSEcCtD
Nitroglycerin—Shock—Doxorubicin—urinary bladder cancer	0.000498	0.000861	CcSEcCtD
Nitroglycerin—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000497	0.000858	CcSEcCtD
Nitroglycerin—Tachycardia—Doxorubicin—urinary bladder cancer	0.000494	0.000854	CcSEcCtD
Nitroglycerin—Skin disorder—Doxorubicin—urinary bladder cancer	0.000492	0.00085	CcSEcCtD
Nitroglycerin—Paraesthesia—Epirubicin—urinary bladder cancer	0.000491	0.000849	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00049	0.000846	CcSEcCtD
Nitroglycerin—Dyspnoea—Epirubicin—urinary bladder cancer	0.000488	0.000843	CcSEcCtD
Nitroglycerin—Somnolence—Epirubicin—urinary bladder cancer	0.000487	0.000841	CcSEcCtD
Nitroglycerin—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000482	0.000833	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000478	0.000826	CcSEcCtD
Nitroglycerin—Hypotension—Doxorubicin—urinary bladder cancer	0.000473	0.000818	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000473	0.000816	CcSEcCtD
Nitroglycerin—Urticaria—Methotrexate—urinary bladder cancer	0.000465	0.000803	CcSEcCtD
Nitroglycerin—Abdominal pain—Methotrexate—urinary bladder cancer	0.000462	0.000799	CcSEcCtD
Nitroglycerin—Body temperature increased—Methotrexate—urinary bladder cancer	0.000462	0.000799	CcSEcCtD
Nitroglycerin—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000455	0.000786	CcSEcCtD
Nitroglycerin—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000452	0.00078	CcSEcCtD
Nitroglycerin—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000451	0.000779	CcSEcCtD
Nitroglycerin—Somnolence—Doxorubicin—urinary bladder cancer	0.00045	0.000778	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000448	0.000773	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000437	0.000755	CcSEcCtD
Nitroglycerin—Urticaria—Epirubicin—urinary bladder cancer	0.000435	0.000751	CcSEcCtD
Nitroglycerin—Abdominal pain—Epirubicin—urinary bladder cancer	0.000433	0.000748	CcSEcCtD
Nitroglycerin—Body temperature increased—Epirubicin—urinary bladder cancer	0.000433	0.000748	CcSEcCtD
Nitroglycerin—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000431	0.000744	CcSEcCtD
Nitroglycerin—Asthenia—Methotrexate—urinary bladder cancer	0.00042	0.000725	CcSEcCtD
Nitroglycerin—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000417	0.000721	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000414	0.000716	CcSEcCtD
Nitroglycerin—Pruritus—Methotrexate—urinary bladder cancer	0.000414	0.000715	CcSEcCtD
Nitroglycerin—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000403	0.000697	CcSEcCtD
Nitroglycerin—Urticaria—Doxorubicin—urinary bladder cancer	0.000402	0.000695	CcSEcCtD
Nitroglycerin—Abdominal pain—Doxorubicin—urinary bladder cancer	0.0004	0.000692	CcSEcCtD
Nitroglycerin—Body temperature increased—Doxorubicin—urinary bladder cancer	0.0004	0.000692	CcSEcCtD
Nitroglycerin—Asthenia—Epirubicin—urinary bladder cancer	0.000393	0.000678	CcSEcCtD
Nitroglycerin—Pruritus—Epirubicin—urinary bladder cancer	0.000387	0.000669	CcSEcCtD
Nitroglycerin—Dizziness—Methotrexate—urinary bladder cancer	0.000387	0.000668	CcSEcCtD
Nitroglycerin—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000373	0.000645	CcSEcCtD
Nitroglycerin—Vomiting—Methotrexate—urinary bladder cancer	0.000372	0.000642	CcSEcCtD
Nitroglycerin—Rash—Methotrexate—urinary bladder cancer	0.000369	0.000637	CcSEcCtD
Nitroglycerin—Dermatitis—Methotrexate—urinary bladder cancer	0.000368	0.000637	CcSEcCtD
Nitroglycerin—Headache—Methotrexate—urinary bladder cancer	0.000366	0.000633	CcSEcCtD
Nitroglycerin—Asthenia—Doxorubicin—urinary bladder cancer	0.000363	0.000628	CcSEcCtD
Nitroglycerin—Dizziness—Epirubicin—urinary bladder cancer	0.000362	0.000625	CcSEcCtD
Nitroglycerin—Pruritus—Doxorubicin—urinary bladder cancer	0.000358	0.000619	CcSEcCtD
Nitroglycerin—Vomiting—Epirubicin—urinary bladder cancer	0.000348	0.000601	CcSEcCtD
Nitroglycerin—Nausea—Methotrexate—urinary bladder cancer	0.000347	0.0006	CcSEcCtD
Nitroglycerin—Rash—Epirubicin—urinary bladder cancer	0.000345	0.000596	CcSEcCtD
Nitroglycerin—Dermatitis—Epirubicin—urinary bladder cancer	0.000345	0.000596	CcSEcCtD
Nitroglycerin—Headache—Epirubicin—urinary bladder cancer	0.000343	0.000592	CcSEcCtD
Nitroglycerin—Dizziness—Doxorubicin—urinary bladder cancer	0.000335	0.000579	CcSEcCtD
Nitroglycerin—Nausea—Epirubicin—urinary bladder cancer	0.000325	0.000562	CcSEcCtD
Nitroglycerin—Vomiting—Doxorubicin—urinary bladder cancer	0.000322	0.000556	CcSEcCtD
Nitroglycerin—Rash—Doxorubicin—urinary bladder cancer	0.000319	0.000552	CcSEcCtD
Nitroglycerin—Dermatitis—Doxorubicin—urinary bladder cancer	0.000319	0.000551	CcSEcCtD
Nitroglycerin—Headache—Doxorubicin—urinary bladder cancer	0.000317	0.000548	CcSEcCtD
Nitroglycerin—Nausea—Doxorubicin—urinary bladder cancer	0.000301	0.00052	CcSEcCtD
